These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2558819)

  • 1. Measurement of angiotensin II concentration in rat plasma: pathophysiological applications.
    Huang H; Baussant T; Reade R; Michel JB; Corvol P
    Clin Exp Hypertens A; 1989; 11(8):1535-48. PubMed ID: 2558819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma angiotensins and blood pressure during converting enzyme inhibition.
    Mento PF; Wilkes BM
    Hypertension; 1987 Jun; 9(6 Pt 2):III42-8. PubMed ID: 3036705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    Hypertension; 1986 Jun; 8(6):476-82. PubMed ID: 3011664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-(1-7). A member of circulating angiotensin peptides.
    Kohara K; Brosnihan KB; Chappell MC; Khosla MC; Ferrario CM
    Hypertension; 1991 Feb; 17(2):131-8. PubMed ID: 1846840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    J Lab Clin Med; 1984 Feb; 103(2):304-12. PubMed ID: 6319516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive method for precise measurement of endogenous angiotensins I, II&III in human plasma.
    Kawamura M; Yoshida K; Akabane S; Matsushima Y; Kawano Y; Kojima S; Takahashi N; Shimamoto K; Ito K; Omae T
    Clin Exp Hypertens A; 1987; 9(2-3):687-91. PubMed ID: 3608206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin I, II, and III in sheep. A model of angiotensin production and metabolism.
    Fei DT; Scoggins BA; Tregear GW; Coghlan JP
    Hypertension; 1981; 3(6):730-7. PubMed ID: 7028609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of plasma angiotensin II: purification by cation-exchange chromatography.
    Ledwith BJ; Cahill MK; Losse LS; Satiritz SM; Eydelloth RS; Dallob AL; Tanaka WK; Galloway SM; Nichols WW
    Anal Biochem; 1993 Sep; 213(2):349-55. PubMed ID: 8238911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma angiotensins under sustained converting enzyme inhibition with enalapril in normal humans.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    J Hypertens Suppl; 1985 Dec; 3(3):S269-70. PubMed ID: 2856820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of angiotensin II release from isolated mesenteric arteries of Wistar-Kyoto and spontaneously hypertensive rats following nephrectomy.
    Shi SJ; Rakugi H; Higashimori K; Higaki J; Mikami H; Ogihara T
    Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):767-73. PubMed ID: 7867227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a sensitive, accurate and robust liquid chromatography/mass spectrometric method for profiling of angiotensin peptides in plasma and its application for atherosclerotic mice.
    Olkowicz M; Radulska A; Suraj J; Kij A; Walczak M; Chlopicki S; Smolenski RT
    J Chromatogr A; 2015 May; 1393():37-46. PubMed ID: 25817477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and childhood.
    Fiselier TJ; Lijnen P; Monnens L; van Munster P; Jansen M; Peer P
    Eur J Pediatr; 1983 Oct; 141(1):3-7. PubMed ID: 6315441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octapeptide-specific and sensitive assay for angiotensin II in plasma.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    Int J Environ Anal Chem; 1986; 25(1-3):257-68. PubMed ID: 3744659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. True versus immunoreactive angiotensin II in human plasma.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    Hypertension; 1985; 7(3 Pt 2):I1-7. PubMed ID: 2987122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy].
    Shamkhlova MSh; Trubitsyna NP; Katsaia GV; Goncharov NP; Malysheva NM; Il'in AV; Nikankina LV; Koshel' LV; Shestakova MV
    Ter Arkh; 2008; 80(1):49-52. PubMed ID: 18326228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrectomy, converting enzyme inhibition, and angiotensin peptides.
    Campbell DJ; Kladis A; Duncan AM
    Hypertension; 1993 Oct; 22(4):513-22. PubMed ID: 8406656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
    Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
    Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat.
    Harding JW; Yoshida MS; Dilts RP; Woods TM; Wright JW
    J Neurochem; 1986 Apr; 46(4):1292-7. PubMed ID: 3950629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-mediated modulation of aldosterone secretion: impact of converting enzyme inhibition on rat glomerulosa cell response to angiotensin-II.
    Braley LM; Menachery A; Rystedt L; Williams GH
    Endocrinology; 1989 Sep; 125(3):1310-4. PubMed ID: 2547581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.